19 C
Hubli
Sunday, January 23, 2022
HomeNationalBharath Biotech's Covaxin gets emergency use approval by DGCI for the 12-18...

Use the Hubli Express app to get Breaking news and headlines. Download now

Bharath Biotech’s Covaxin gets emergency use approval by DGCI for the 12-18 age group.

The Drugs Controller General of India (DGCI) has granted Bharat Biotech emergency use authorization for its COVID-19 vaccine Covaxin for the 12–18 year age group. The Health and Family Welfare Minister of Karnataka tweeted Dr. K Sudhakar.

( Courtesy: Dr. K Sudhakar, Health and Family Welfare Minister on Twitter)

The Hubli Express is on WhatsApp now, you can join the WhatsApp group by clicking the link 

https://chat.whatsapp.com/JKJecHdlD3X1Q2qkrpv0YT

You can follow us on Facebook @HubliExpress

or

Twitter Check out Kishan Rajput (@KishanExpress):

https://twitter.com/KishanExpress?t=9XwL68NC_UTuPXecuK4-rg&s=08

 

 

The Hubli Express Is On Whatsapp Now, You Can Join The Whatsapp Group By Clicking The Link

Use the Hubli Express app to get Breaking news and headlines. Download now

LEAVE A REPLY

Please enter your comment!
Please enter your name here

error: Content is protected !!